ODI Pharma AB (publ) (NGM:ODI)

ODI Pharma AB Revenue

ODI Pharma AB had revenue of 5.97M SEK in the quarter ending September 30, 2025, with 4,050.37% growth. This brings the company's revenue in the last twelve months to 8.96M, down -59.10% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.13M, down -85.94%.

• Revenue (ttm): 8.96M
• Revenue Growth: -59.10%
• P/S Ratio: 6.88
• Revenue / Employee: 8.96M
• Employees: 1
• Market Cap: 61.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.13M	-19.15M	-85.94%
Jun 30, 2024	22.29M	22.15M	15,880.34%
Jun 30, 2023	139.46K	-173.48K	-55.44%
Jun 30, 2022	312.94K	-	-
Jun 30, 2021	-	-	-